Company Filing History:
Years Active: 2014
Title: Olav Michael Andersen: Innovator in Neurotrophin Modulation
Introduction
Olav Michael Andersen is a notable inventor based in Skamby, Denmark. He has made significant contributions to the field of neurobiology through his innovative research and patenting activities. His work focuses on the modulation of neurotrophins, which are crucial for the development and function of the nervous system.
Latest Patents
Andersen holds a patent titled "Modulation of activity of proneurotrophins." This invention provides agents that inhibit the binding of pro-neurotrophins to Vps1 Op-domain receptors. Specifically, it addresses the binding of pro-NGF or pro-BDNF to the Sortilin receptor. The implications of this invention are profound, as it offers potential treatments for various diseases and disorders, including neurological, neuropsychiatric, and ocular conditions, as well as obesity, diabetes, and pain management. He has 1 patent to his name.
Career Highlights
Olav Michael Andersen is associated with H. Lundbeck A/S, a prominent pharmaceutical company known for its focus on brain diseases. His role at Lundbeck allows him to contribute to the development of innovative therapies that can improve the quality of life for individuals suffering from complex neurological disorders.
Collaborations
Andersen has collaborated with notable colleagues, including Anders Nykjaer and Anders Nykjær. These partnerships enhance the research and development efforts in the field of neurobiology, fostering innovation and discovery.
Conclusion
Olav Michael Andersen's work in the modulation of proneurotrophins represents a significant advancement in the treatment of various neurological disorders. His contributions through patenting and collaboration continue to pave the way for future innovations in medicine.